Manufacturer
Alkermes
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 15
- Molecules
- 4
- Therapy areas
- 1
Alkermes is a pharmaceutical manufacturer based in United States. MedsAcross lists 15 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Alkermes, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Alkermes products through licensed channels, with the documents your regulator needs.
Neurology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lumryz kit | Sodium oxybate | US FDA | Available on request |
| Lumryz 4.5 g powder for extended-release oral suspensionOral | Sodium oxybate | US FDA | Available on request |
| Lumryz 6 g powder for extended-release oral suspensionOral | Sodium oxybate | US FDA | Available on request |
| Lumryz 7.5 g powder for extended-release oral suspensionOral | Sodium oxybate | US FDA | Available on request |
| Lumryz 9 g powder for extended-release oral suspensionOral | Sodium oxybate | US FDA | Available on request |
| Vivitrol kit Cold chain | Naltrexone | US FDA | Available on request |
Other products
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aristada 1064 mg/3.9 mL extended-release injectable suspensionIntramuscular | Aripiprazole lauroxil | US FDA | Available on request |
| Aristada 441 mg/1.6 mL extended-release injectable suspensionIntramuscular | Aripiprazole lauroxil | US FDA | Available on request |
| Aristada 662 mg/2.4 mL extended-release injectable suspensionIntramuscular | Aripiprazole lauroxil | US FDA | Available on request |
| Aristada 882 mg/3.2 mL extended-release injectable suspensionIntramuscular | Aripiprazole lauroxil | US FDA | Available on request |
| Aristada Initio 675 mg/2.4 mL extended-release injectable suspensionIntramuscular | Aripiprazole lauroxil | US FDA | Available on request |
| Lybalvi 10 mg/10 mg tabletOral | Olanzapine and Samidorphan l-malate | US FDA | Available on request |
| Lybalvi 15 mg/10 mg tabletOral | Olanzapine and Samidorphan l-malate | US FDA | Available on request |
| Lybalvi 20 mg/10 mg tabletOral | Olanzapine and Samidorphan l-malate | US FDA | Available on request |
| Lybalvi 5 mg/10 mg tabletOral | Olanzapine and Samidorphan l-malate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Alkermes
Send a request for any of these products. We confirm the licensed source, documents and lead time.